Sun Pharma has announced that effective August 2016, Abhay Gandhi will take over as CEO, North America Business.
Sun Pharma has announced that effective August 2016, Abhay Gandhi will take over as CEO, North America Business.
Kal Sundaram will assume the position of CEO-India business and emerging markets.
Sun Pharma has announced that effective August 2016, Abhay Gandhi will take over as CEO, North America Business.Kal Sundaram will assume the position of CEO-India business and emerging markets.
Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 790.9, up by Rs. 7.15 or 0.91% from its previous closing of Rs. 783.75 on the BSE.
The scrip opened at Rs. 789 and has touched a high and low of Rs. 794.75 and Rs. 775.55 respectively. So far 1252947(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 188629.34 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 965.15 on 20-Aug-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 793.25 and Rs. 774.8 respectively.
The promoters holding in the company stood at 54.97 % while Institutions and Non-Institutions held 35.37 % and 9.65 % respectively.
The stock is currently trading above its 200 DMA.
No comments:
Post a Comment